EBS
Price
$2.54
Change
-$0.06 (-2.31%)
Updated
Mar 28, 6:59 PM EST
28 days until earnings call
RGEN
Price
$183.92
Change
-$0.83 (-0.45%)
Updated
Mar 28, 6:59 PM EST
27 days until earnings call
Ad is loading...

Compare trend and price EBS vs RGEN

Header iconEBS vs RGEN Comparison
Open Charts EBS vs RGENBanner chart's image
Emergent Biosolutions
Price$2.54
Change-$0.06 (-2.31%)
Volume$370.31K
CapitalizationN/A
Repligen
Price$183.92
Change-$0.83 (-0.45%)
Volume$146.99K
CapitalizationN/A
View a ticker or compare two or three
EBS vs RGEN Comparison Chart

Loading...

EBSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
EBS vs. RGEN commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EBS is a StrongBuy and RGEN is a StrongSell.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (EBS: $2.54 vs. RGEN: $183.92)
Brand notoriety: EBS and RGEN are both not notable
EBS represents the Pharmaceuticals: Other, while RGEN is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EBS: 10% vs. RGEN: 28%
Market capitalization -- EBS: $135.21M vs. RGEN: $10.3B
EBS [@Pharmaceuticals: Other] is valued at $135.21M. RGEN’s [@Medical Specialties] market capitalization is $10.3B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.16B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $2.97B. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EBS’s FA Score shows that 1 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • EBS’s FA Score: 1 green, 4 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than EBS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EBS’s TA Score shows that 7 TA indicator(s) are bullish while RGEN’s TA Score has 4 bullish TA indicator(s).

  • EBS’s TA Score: 7 bullish, 3 bearish.
  • RGEN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, EBS is a better buy in the short-term than RGEN.

Price Growth

EBS (@Pharmaceuticals: Other) experienced а +2.63% price change this week, while RGEN (@Medical Specialties) price change was -7.92% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.73%. For the same industry, the average monthly price growth was +5.34%, and the average quarterly price growth was +13.58%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.79%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was +4.33%.

Reported Earning Dates

EBS is expected to report earnings on Apr 25, 2024.

RGEN is expected to report earnings on Apr 24, 2024.

Industries' Descriptions

@Pharmaceuticals: Other (+8.73% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+0.79% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for EBS with price predictions.
OPEN
A.I.dvisor published
a Summary for RGEN with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RGEN($10.3B) has a higher market cap than EBS($135M). RGEN has higher P/E ratio than EBS: RGEN (249.59) vs EBS (17.73). EBS YTD gains are higher at: 5.625 vs. RGEN (2.291). RGEN has higher annual earnings (EBITDA): 134M vs. EBS (-518.2M). RGEN has more cash in the bank: 751M vs. EBS (112M). RGEN has less debt than EBS: RGEN (712M) vs EBS (860M). EBS has higher revenues than RGEN: EBS (1.02B) vs RGEN (639M).
EBSRGENEBS / RGEN
Capitalization135M10.3B1%
EBITDA-518.2M134M-387%
Gain YTD5.6252.291245%
P/E Ratio17.73249.597%
Revenue1.02B639M160%
Total Cash112M751M15%
Total Debt860M712M121%
FUNDAMENTALS RATINGS
EBS vs RGEN: Fundamental Ratings
EBS
RGEN
OUTLOOK RATING
1..100
762
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
10048
SMR RATING
1..100
9888
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
185
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EBS's Valuation (66) in the Biotechnology industry is in the same range as RGEN (90). This means that EBS’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's Profit vs Risk Rating (48) in the Biotechnology industry is somewhat better than the same rating for EBS (100). This means that RGEN’s stock grew somewhat faster than EBS’s over the last 12 months.

RGEN's SMR Rating (88) in the Biotechnology industry is in the same range as EBS (98). This means that RGEN’s stock grew similarly to EBS’s over the last 12 months.

RGEN's Price Growth Rating (50) in the Biotechnology industry is in the same range as EBS (50). This means that RGEN’s stock grew similarly to EBS’s over the last 12 months.

RGEN's P/E Growth Rating (5) in the Biotechnology industry is in the same range as EBS (18). This means that RGEN’s stock grew similarly to EBS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EBSRGEN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
72%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
72%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 11 days ago
74%
Bullish Trend 10 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 3 days ago
74%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
EBSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RGENDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMYYX39.69N/A
N/A
Putnam Core Equity Fund Y
USTCX24.38N/A
N/A
Victory Science & Technology Class A
DFSGX24.10N/A
N/A
DF Dent Small Cap Growth Institutional
LTAGX14.04N/A
N/A
Lord Abbett International Growth R5
AILLX22.98N/A
N/A
Aristotle Core Equity I-2